Clinical Trial

Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

Study acronym: SOLUTION2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter, open-label, non-inferiority, randomized controlled, investigator-initiated clinical trial comparing the efficacy and safety of open radical hysterectomy versus minimally invasive radical hysterectomy using an endoscopic stapler as surgical treatments for early cervical cancer.
Trial Details
NCT Number NCT07256977
Lead Sponsor Seoul National University Hospital
Collaborators: Ajou University School of Medicine, SMG-SNU Boramae Medical Center, Konkuk University, DongGuk University, Keimyung University, National Cancer Center, Korea, The Catholic University of Korea, Wonju Severance Christian Hospital, Kangbuk Samsung Hospital, Asan Medical Center, Samsung Medical Center, Sinchon Severance Hospital, Yonsei University College of Medicine
Conditions Cervical Cancer Stage IB2, Cervical Cancer Stage IIa
Enrollment 494 participants
Start Date 2026-01-01
Primary Completion 2034-12-31 (estimated)
Study Completion 2035-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-02